The PERMIT project aims to build recommendations for robust and reproducible personalised medicine research. A first stage of the project focuses on performing a review of existing literature to map existing methodologies and identify gaps and opportunities for recommendations. The protocol for this scoping review project has been made publicly available, and now an abstract of this methodology has been published in a special issue of the Cochrane Library, entitled Advances in Evidence Synthesis. This abstract was submitted by the PERMIT project for the Cochrane Colloquium 2020, but due to the COVID-19 pandemic this event was postponed until September 2022. The abstract was nevertheless selected by the organizers to be part of this special edition and can be found online (p403).

@EatrisEric
Jan 17th
A new publication about robust & reproducible preclinical research in #PersonalisedMedicine has been published in BMCMedicine. Among the authors are EATRIS staff & institutions members. Congrats to all involved.
👉Find out more hereatris.eu/news/new-publi…w#PERMITprojectect https://t.co/kp46SdWB9G


@PaulaGarLobato
Jan 11th
Catch up on your reading! The #PERMITproject has a new publication! twitter.com/ECRIN_ERIC/sta…

@ECRIN_ERIC
Jan 11th
New #PERMITProject publication: Recommendations for robust & reproducible preclinical research in personalised medicine.
15 recommendations are presented aiming to improve the robustness of preclinical methods in translational research for PM.
permit-eu.org/publications https://t.co/zAS8pYOlOm
